Video Back Videos home Signature collection Essentials collection Artificial Intelligence Trending searches ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) released interim data from a Phase 1 trial evaluating soquelitinib in patients with moderate to severe atopic dermatitis. The trial will enroll 64 ...

Corvus Pharmaceuticals shares interim Phase 1 trial data showing promising results for soquelitinib in treating moderate to severe atopic dermatitis.

Corvus Pharmaceuticals (NASDAQ:CRVS) lost ~34% in the premarket on Wednesday after the company announced early results from a Phase 1 trial for its lead asset, soquelitinib, in patients with ...

Heather Khalifa / Bloomberg / Getty Images Shares of Constellation Energy rose Thursday after analysts from Bank of America upgraded and lifted their price target for the stock. The analysts said ...

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) just reported positive results from its phase 1 study using soquelitinib [CPI-818] for the treatment of patients with atopic dermatitis [AD]. Being that ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BURLINGAME, Calif., Dec. 18, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced interim ...

A total of 1014 guests have reviewed Celebrity Constellation, giving it a rating of 4 on a scale of 1-5. Celebrity Retire This Ship! Please..Please! Jan 2nd, 2025 Aqua Class is so not worth it on ...

Today, a brief rundown of news involving Tessera Therapeutics and Corvus Pharmaceuticals, as well as updates from Sarepta Therapeutics, Cara Therapeutics and Johnson & Johnson that you may have missed ...